Bright Minds Biosciences Inc (DRUG) — Financial Flexibility Index
Bright Minds Biosciences Inc (DRUG) has a Financial Flexibility Index of -2.48x as of March 2026. Free cash flow of $-9.50 Million (operating CF $-9.50 Million minus capex $4.18) represents -2% of total liabilities ($3.83 Million). Check Bright Minds Biosciences Inc (DRUG) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bright Minds Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Bright Minds Biosciences Inc across 7 annual periods. See working capital position of Bright Minds Biosciences Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bright Minds Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Bright Minds Biosciences Inc. For the full company profile including market capitalisation, see Bright Minds Biosciences Inc (DRUG) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.66x | $-8.69 Million | $-8.69 Million | $2.38 Million | ▼ -12.3% |
| 2024 | -3.26x | $-1.85 Million | $-1.85 Million | $568.26K | ▲ +87.0% |
| 2023 | -25.01x | $-7.02 Million | $-7.02 Million | $280.86K | ▼ -184.3% |
| 2022 | -8.80x | $-13.59 Million | $-13.59 Million | $1.54 Million | ▲ +23.2% |
| 2021 | -11.46x | $-7.32 Million | $-7.32 Million | $638.57K | ▼ -499.8% |
| 2020 | -1.91x | $-288.39K | $-288.39K | $150.92K | ▼ -67.0% |
| 2019 | -1.14x | $-42.01K | $-42.01K | $36.71K | — |